Feb. 28, 2019—Vanderbilt’s newest endowed chair holders were celebrated for their path-breaking scholarship and research by family members, donors, colleagues and friends during a Feb. 25 ceremony.
Aug. 6, 2018—The computer-aided design and engineering of antibodies and vaccine candidates that can neutralize viral scourges like influenza and Ebola will be the topic of an Aug. 17 poster session presented by the Vanderbilt Center for Structural Biology and the Vanderbilt Vaccine Center.
Apr. 18, 2018—A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger.
New working group to assess and prioritize opportunities for enhancing research IT resources on campus
Mar. 17, 2017—The Research IT Special Project Working Group will advance the efforts of the Provost’s Initiative to Enhance Research and Scholarship, or PIERS.
Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.
Jun. 2, 2016—High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.
Apr. 7, 2016—It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.
Feb. 5, 2016—Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance.
Dec. 15, 2015—Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany.
Jul. 31, 2015—Vanderbilt researchers have received a five-year, $9 million grant from the National Institutes of Health to design more effective flu vaccines and novel antibody therapies.
May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.
May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.